Route 92 Medical Stock
Route 92 Medical is a medical device company developing a catheter to treat stroke.
Sign up today and learn more about Route 92 Medical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Route 92 Medical Stock
Route 92 Medical is a developer of a stealthy catheter for stroke treatment. The company was founded in 2015 and based in San Mateo, California.
Funding History
| May 2016 | $5.9M |
|---|---|
| May 2017 | $5.9M |
| August 2018 | $4.7M |
| May 2019 | $13.0M |
| December 2021 | $56.0M |
| December 2021 | $55.0M |
Management
Sr. VP Clinical, Regulatory and Quality
Kirsten Valley
Board Member
Ariella Golomb
Chief Medical Officer and Co-Founder
Joey English
General Partner @ The Vertical Group
Jack W. Lasersohn
Board Observer
Robert Mittendorff
Founder and CEO
Tony M. Chou
Press
fiercebiotech - Dec, 16 2021
Route 92 Medical collects $111M for its brain blood clot-clearing devicessec - Aug, 22 2017
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
